Takuhiro Sonoyama, MD

Senior Clinical
Shionogi & Co., Ltd., Japan

Disclosure(s): Shionogi & Co., Ltd.: Stocks/Bonds (Private Company)

Poster(s):

• (P-2032) The Time to Return to Work in Healthcare Workers With COVID-19 Infection Treated With Ensitrelvir, a Novel Oral Inhibitor of 3C-Like Protease of SARS-COV-2
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT